OPM’s annual guidance to FEHB carriers urges insurers to reduce costs by ending cash incentives tied to childhood vaccine uptake and by requiring therapy or other steps before covering GLP-1 weight-loss drugs. The direction could influence FEHB plan design and prior-authorization rules in upcoming plan years.
Read full story at GovExec — Pay & Benefits →Related Topics
fehbopmhealth-insurance-carriersglp-1obesity-treatmentvaccinesplan-year-guidance